Print

VRC 009 (05-I-0081)

A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Booster Dose of a Recombinant Multiclade HIV-1 Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP, in Uninfected Subjects who were Previously Immunized with VRC-HIVDNA009-00-VP in VRC 004

Trial Details:

I Completed
NIAID,VRC January 01, 2005
VRC-HIVADV014-00-VP,VRC-HIVDNA009-00-VP
VRC-HIVDNA009-00-VP DNA
VRC-HIVADV014-00-VP Viral Vector - Adeno
USA 32
http://www.clinicaltrials.gov/ct/show/NCT00102089?order=3